Holen Sie sich die Stockscreener-App
12.04
0.17%
-0.02
Handel nachbörslich:
12.04
Schlusskurs vom Vortag:
$12.06
Offen:
$12.06
24-Stunden-Volumen:
5,745
Relative Volume:
0.26
Marktkapitalisierung:
$56.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.77M
KGV:
-16.49
EPS:
-0.73
Netto-Cashflow:
$-17.36M
1W Leistung:
+6.36%
1M Leistung:
+4.70%
6M Leistung:
+66.50%
1J Leistung:
+33.50%
1-Tages-Spanne:
$11.85
$12.18
1-Wochen-Bereich:
$10.88
$12.18
52-Wochen-Spanne:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Firmenname
Mink Therapeutics Inc
Sektor
Branche
Telefon
212-994-8250
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie INKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
12.04 | 56.61M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Aktie (INKT) Neueste Nachrichten
MiNK Therapeutics (NASDAQ:INKT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
MiNK Therapeutics announces board resignation amid public appointment - TipRanks
Treasury Yields: How MiNK Therapeutics Inc 6Q40 stock responds to job market shiftsDay Trade & Real-Time Volume Triggers - moha.gov.vn
Risk Report: Will MiNK Therapeutics Inc 6Q40 stock enhance shareholder valueWeekly Trade Review & Precise Trade Entry Recommendations - moha.gov.vn
The Technical Signals Behind (INKT) That Institutions Follow - Stock Traders Daily
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of “Hold” from Analysts - Defense World
MiNK Therapeutics, Inc. Financial Statements – GETTEX:6Q40 - TradingView — Track All Markets
Will MiNK Therapeutics Inc. stock reach all time highs in 2025Jobs Report & Fast Momentum Stock Entry Tips - Улправда
Published on: 2025-12-21 01:45:03 - Улправда
Why MiNK Therapeutics Inc. stock attracts global investors2025 Market Trends & Short-Term High Return Ideas - Улправда
Signal Recap: Why MiNK Therapeutics Inc. (6Q40) stock could rally strongly2025 Geopolitical Influence & Safe Entry Zone Identification - moha.gov.vn
Wall Street Zen Downgrades MiNK Therapeutics (NASDAQ:INKT) to Sell - Defense World
Can MiNK Therapeutics Inc. stock deliver consistent earnings growth2025 AllTime Highs & Free Growth Oriented Trading Recommendations - Улправда
Published on: 2025-12-20 10:06:06 - Улправда
Total debt per share of MiNK Therapeutics, Inc. – MUN:6Q40 - TradingView — Track All Markets
Why MiNK Therapeutics Inc. stock is seen as undervaluedJuly 2025 Sector Moves & AI Based Trade Execution Alerts - Улправда
Is MiNK Therapeutics Inc. stock in correction or buying zone2025 Price Action Summary & Free High Return Stock Watch Alerts - Улправда
Will MiNK Therapeutics Inc. stock split again soonWeekly Investment Recap & Accurate Entry/Exit Alerts - DonanımHaber
Why MiNK Therapeutics Inc. (6Q40) stock could rally stronglyJuly 2025 Gainers & Real-Time Buy Signal Notifications - DonanımHaber
Published on: 2025-12-19 11:33:23 - Улправда
Published on: 2025-12-19 08:39:05 - Улправда
Trading Systems Reacting to (INKT) Volatility - Stock Traders Daily
Bond Watch: Is MiNK Therapeutics Inc. stock in correction or buying zoneJuly 2025 Update & Community Consensus Trade Signals - BỘ NỘI VỤ
Why MiNK Therapeutics Inc. stock is favored by top institutionsWeekly Trading Summary & Community Verified Trade Signals - Newser
How Mink Therapeutics Inc. (INKT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilientQuarterly Profit Report & Daily Growth Stock Tips - Newser
What downside risks could hit MiNK Therapeutics Inc. (6Q40) stockJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
MiNK Therapeutics (INKT) Stock Analysis Report | Financials & Insights - Benzinga
Why MiNK Therapeutics Inc. (6Q40) stock appeals to dividend investorsQuarterly Trade Summary & Growth Focused Entry Point Reports - Newser
MiNK Therapeutics (INKT) director awarded 1,263 RSUs for board service - Stock Titan
Will MiNK Therapeutics Inc. (6Q40) stock recover faster than industryStock Surge & Momentum Based Trading Signals - Newser
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-12-02 06:12:45 - Newser
Will MiNK Therapeutics Inc. (6Q40) stock outperform value peersMarket Activity Recap & Target Return Focused Stock Picks - Newser
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Aug Opening: Why MiNK Therapeutics Inc. stock attracts global investorsAnalyst Downgrade & AI Based Buy/Sell Signal Reports - moha.gov.vn
(INKT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
MiNK Therapeutics Inc 6Q40 Stock Analysis and ForecastBull Market Opportunities & Learn From the Strategies of Institutions - earlytimes.in
MiNK Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Small Capital Trading Plans - earlytimes.in
MiNK Therapeutics announces publication of new preclinical data for MiNK-215 - MSN
How reliable is MiNK Therapeutics Inc. (6Q40) stock dividend growthEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors - The Manila Times
MiNK Therapeutics Advances iNKT Platform in Q3 2025 - MSN
MiNK Therapeutics Announces New Data Showing MiNK-215 - GlobeNewswire
MiNK Therapeutics (NASDAQ: INKT) unveils MiNK-215 CAR-iNKT for solid tumors - Stock Titan
Why global investors buy MiNK Therapeutics Inc. (6Q40) stock - newser.com
How MiNK Therapeutics Inc. stock performs in rate cut cyclesBond Market & Community Shared Stock Ideas - newser.com
Mink Therapeutics Shares Slide After Announcing $50 Million Stock Offering - MSN
FY2025 EPS Estimate for MiNK Therapeutics Raised by Analyst - Defense World
Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):